IDSA/PIDS
Pediatric pneumonia guideline update emphasizes less invasive care
This 2026 IDSA/PIDS guideline updates the prior 2011 pediatric community acquired pneumonia (CAP) guidance, reflecting changes in epidemiology, diagnostics, and management over the past 15 years. The update primarily focuses on complicated CAP (parapneumonic effusion/empyema) and applies GRADE methodology, with most recommendations being conditional and based on low‑certainty evidence. Importantly, core empiric antibiotic choices for uncomplicated CAP remain largely unchanged, while procedural and adjunctive management strategies are refined.
What’s new (2026 vs. 2011)
No major changes to empiric antibiotic regimens for uncomplicated CAP. The update primarily addresses pneumonia with parapneumonic effusion/empyema; core antimicrobial recommendations (eg, narrow‑spectrum beta‑lactams as first line, selective use of macrolides or MRSA coverage based on clinical risk) are largely unchanged from prior guidance.
Shift toward less invasive management alongside antibiotics for complicated CAP:
- Small, uncomplicated parapneumonic effusions: observation plus antibiotics favored over routine drainage.
- Moderate effusions with respiratory distress or large/purulent effusions: pleural drainage recommended (unchanged from 2011).
Intrapleural fibrinolysis: drug-specific change
- tPA alone is now preferred over tPA + DNase for children with pneumonia‑associated empyema requiring fibrinolysis (conditional recommendation, low‑certainty evidence).
Procedural approach refined (impacts adjunctive therapy decisions):
- Chest tube drainage with fibrinolytics favored over upfront surgical debridement (VATS) in most cases.
- Small‑bore chest tubes (≤12 Fr) preferred when drainage is needed.
- Chest ultrasound recommended over CT/MRI to characterize moderate–large effusions, reducing radiation exposure.
Clinical takeaway: Antibiotic choices for pediatric CAP remain familiar, but management of complicated cases now prioritizes conservative, less invasive strategies and simpler fibrinolytic therapy (tPA alone) alongside appropriate antimicrobials.
Source:
Infectious Diseases Society of America; Pediatric Infectious Diseases Society. IDSA/PIDS 2026 Guidelines for the Management of Community‑Acquired Pneumonia in Infants and Children Older Than 3 Months of Age. Published Feb 24, 2026. Available at: https://www.idsociety.org/practice-guideline/community-acquired-pneumonia-in-infants-and-children/